Search research articles
Contact Us
Filters
Showing results (51-60 of 115) with videos related to
Page
of 12
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 17, 2026
Multidisciplinary Care of Patients With Penile Cancer
Luis G Medina, Firas Hatoum, Nahuel Paesano, et al.
Nature Reviews. Urology
|
January 18, 2024
A clinical overview of people living with HIV and genitourinary cancer care
Chalairat Suk-Ouichai, Anna E Coghill, Matthew B Schabath, et al.
BJU International
|
May 3, 2025
Early postoperative visits improve outcomes in inguinal lymph node dissection for penile cancer
Adnan Fazili, R Barry Sirard, Zachary Thompson, et al.
Frontiers in Oncology
|
March 1, 2021
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
Jacob J Adashek, Yumeng Zhang, William Paul Skelton, et al.
Cancers
|
January 25, 2025
Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas
Justin W Miller, Jeffrey S Johnson, Christopher Guske, et al.
Investigational New Drugs
|
March 26, 2021
Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial
Andrew W Hahn, Jad Chahoud, Matthew T Campbell, et al.
The Oncologist
|
March 13, 2020
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis
Jad Chahoud, Pavlos Msaouel, Matthew T Campbell, et al.
Clinical Genitourinary Cancer
|
March 7, 2022
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer
Jonathan Chatzkel, Michael J Schell, Jad Chahoud, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Nadine Mahmoud, Arfa Mustasam, Justin Miller, et al.
European Urology Oncology
|
April 30, 2025
Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab Trial
Rohit K Jain, Umang Swami, Mehmet A Bilen, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 115) with videos related to
Sort By:
Page
of 12
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 17, 2026
Multidisciplinary Care of Patients With Penile Cancer
Luis G Medina, Firas Hatoum, Nahuel Paesano, et al.
Nature Reviews. Urology
|
January 18, 2024
A clinical overview of people living with HIV and genitourinary cancer care
Chalairat Suk-Ouichai, Anna E Coghill, Matthew B Schabath, et al.
BJU International
|
May 3, 2025
Early postoperative visits improve outcomes in inguinal lymph node dissection for penile cancer
Adnan Fazili, R Barry Sirard, Zachary Thompson, et al.
Frontiers in Oncology
|
March 1, 2021
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
Jacob J Adashek, Yumeng Zhang, William Paul Skelton, et al.
Cancers
|
January 25, 2025
Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas
Justin W Miller, Jeffrey S Johnson, Christopher Guske, et al.
Investigational New Drugs
|
March 26, 2021
Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial
Andrew W Hahn, Jad Chahoud, Matthew T Campbell, et al.
The Oncologist
|
March 13, 2020
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis
Jad Chahoud, Pavlos Msaouel, Matthew T Campbell, et al.
Clinical Genitourinary Cancer
|
March 7, 2022
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer
Jonathan Chatzkel, Michael J Schell, Jad Chahoud, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Nadine Mahmoud, Arfa Mustasam, Justin Miller, et al.
European Urology Oncology
|
April 30, 2025
Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab Trial
Rohit K Jain, Umang Swami, Mehmet A Bilen, et al.
Page
of 12